再生元制药公司(REGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REGN 再生元制药公司

交易中 08-08 15:56:25 EDT

563.12

+3.32

+0.59%

最高567.69	最低558.06	成交量69.95万
今开559.74	昨收559.80	日振幅1.72%
总市值607.97亿	流通市值562.50亿	总股本1.08亿
成交额3.95亿	换手率0.70%	流通股本9,989万
市净率2.03	ROE15.34%	每股收益39.67
52周最高1,211.20	52周最低476.49	市盈率14.19
股息1.76	股息收益率0.00	ROA6.66%

北京优虎网络科技有限公司

{"stockData":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"再生元制药公司","latestPrice":563.115,"timestamp":1754682985210,"preClose":559.8,"halted":0,"volume":699452,"delay":0,"floatShares":99889916,"shares":107965497,"eps":39.673737,"marketStatus":"交易中","change":3.315,"latestTime":"08-08 15:56:25 EDT","open":559.74,"high":567.69,"low":558.0618,"amount":394571574.81560004,"amplitude":0.017199,"askPrice":563.38,"askSize":79,"bidPrice":563.05,"bidSize":28,"shortable":3,"etf":0,"ttmEps":39.673737,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1754683200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":559.8,"dividendRate":0.003125,"preHourTrading":{"tag":"盘前","latestPrice":560,"preClose":559.8,"latestTime":"09:22 EDT","volume":286,"amount":159370.61140000002,"timestamp":1754659365541},"postHourTrading":{"tag":"盘后","latestPrice":559.8,"preClose":559.8,"latestTime":"19:58 EDT","volume":28069,"amount":15713253.4337,"timestamp":1754611086556},"volumeRatio":0.619454,"impliedVol":0.3224,"impliedVolPercentile":0.216},"requestUrl":"/m/hq/s/REGN","defaultTab":"news","newsList":[{"id":"2557154834","title":"再生元制药公司8月7日成交额为4.54亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557154834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557154834?lang=zh_cn&edition=full","pubTime":"2025-08-08 13:41","pubTimestamp":1754631697,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，再生元制药公司成交额为4.54亿美元，成交额较昨日减少5.81%，当日成交量为81.13万股。再生元制药公司于2025年8月7日涨0.84%，报559.8美元，该股过去5个交易日涨2.63%，年初至今跌21.19%，过去60日跌2.6%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808134147a6da4861&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808134147a6da4861&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053666078.USD","LU0320765992.SGD","REGN","LU0058720904.USD","LU0114720955.EUR","BK4139","LU0109394709.USD","LU0823416689.USD","LU2237438978.USD","BK4588","LU2023250504.SGD","LU0823434583.USD","LU2362541513.USD","LU2089984988.USD","LU2106854487.HKD","LU2362540622.SGD","LU2362541273.HKD","LU2468319806.SGD","LU0823434740.USD","LU1917777945.USD","LU0289739699.SGD","BK4585","LU0882574055.USD","LU0889565916.HKD","LU1974910355.USD"],"gpt_icon":0},{"id":"2557536345","title":"再生元制药公司8月6日成交额为4.82亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557536345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557536345?lang=zh_cn&edition=full","pubTime":"2025-08-07 13:35","pubTimestamp":1754544950,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，再生元制药公司成交额为4.82亿美元，成交额较昨日减少15.09%，当日成交量为86.52万股。再生元制药公司于2025年8月6日跌2.59%，报555.13美元，该股过去5个交易日涨0.1%，年初至今跌21.85%，过去60日涨5.34%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807133601a6d80559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807133601a6d80559&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","LU0109394709.USD","LU2237438978.USD","LU0058720904.USD","LU1974910355.USD","LU0289739699.SGD","REGN","LU0823434583.USD","LU0823416689.USD","LU2089984988.USD","LU0053666078.USD","LU0823434740.USD","LU2362540622.SGD","LU2106854487.HKD","BK4588","LU2362541273.HKD","LU0320765992.SGD","LU2023250504.SGD","LU2362541513.USD","LU0882574055.USD","LU2468319806.SGD","BK4139","LU0114720955.EUR","LU1917777945.USD"],"gpt_icon":0},{"id":"2557340369","title":"再生元制药公司8月5日成交额为5.67亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557340369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557340369?lang=zh_cn&edition=full","pubTime":"2025-08-06 13:29","pubTimestamp":1754458165,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，再生元制药公司成交额为5.67亿美元，成交额较昨日减少26.98%，当日成交量为99.35万股。再生元制药公司于2025年8月5日跌0.29%，报569.9美元，该股过去5个交易日涨2.11%，年初至今跌19.77%，过去60日涨4.22%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|5.67亿|-26.98%|99.35万|#|2025-08-04|7.77亿|-15.76%|136.27万|#|2025-08-01|9.22亿|19.03%|165.68万|#|2025-07-31|7.75亿|146.52%|141.38万|#|2025-07-30|3.14亿|-30.83%|56.49万|Regeneron Pharmaceuticals 发现、开发和商业化用于治疗眼部疾病、心血管疾病、癌症和炎症的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806132928a477f956&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806132928a477f956&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2362540622.SGD","BK4588","LU2468319806.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0053666078.USD","LU0889565916.HKD","LU2362541513.USD","LU1917777945.USD","LU0823434740.USD","LU0109394709.USD","LU1974910355.USD","LU2089984988.USD","BK4585","LU0114720955.EUR","BK4139","LU0882574055.USD","LU0320765992.SGD","LU0289739699.SGD","LU2362541273.HKD","LU0823434583.USD","LU2237438978.USD","REGN","LU0058720904.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2557352067","title":"再生元制药公司8月4日成交额为7.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557352067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557352067?lang=zh_cn&edition=full","pubTime":"2025-08-05 13:29","pubTimestamp":1754371759,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，再生元制药公司成交额为7.77亿美元，成交额较昨日减少15.76%，当日成交量为136.27万股。再生元制药公司于2025年8月4日涨2.27%，报571.54美元，该股过去5个交易日涨2.31%，年初至今跌19.54%，过去60日涨2.04%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805132930a475d91d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805132930a475d91d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1974910355.USD","LU2362541273.HKD","BK4585","LU0053666078.USD","BK4139","REGN","LU0823434583.USD","LU0823434740.USD","LU0109394709.USD","LU2468319806.SGD","LU2237438978.USD","LU2089984988.USD","LU2023250504.SGD","LU0823416689.USD","LU0882574055.USD","LU0289739699.SGD","BK4588","LU2106854487.HKD","LU0058720904.USD","LU0320765992.SGD","LU0889565916.HKD","LU2362541513.USD","LU2362540622.SGD","LU0114720955.EUR","LU1917777945.USD"],"gpt_icon":0},{"id":"2556474918","title":"美股财报 | 再生元制药发布Q2财报 前半年累计净利润同比增长2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556474918","media":"同花顺iNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556474918?lang=zh_cn&edition=full","pubTime":"2025-08-02 12:00","pubTimestamp":1754107210,"startTime":"0","endTime":"0","summary":"再生元制药发布Q2财报，2025财年前六月累计收入67.04亿美元，去年同期累计收入为66.92亿美元，同比增长0.18%。2025财年前六月累计净利润22.00亿美元，去年同期累计净利润为21.54亿美元，同比增长2.14%。再生元制药公司于1988年在纽约州成立。再生元制药公司是一家完全集成的生物技术公司，它发现、发明、开发、制造和商业化治疗严重疾病的药物。其目标是继续成为一家综合性、多产品的生物技术公司，为患者和医疗专业人员提供预防和治疗人类疾病的重要选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802120522a470c879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802120522a470c879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REGN"],"gpt_icon":0},{"id":"1153428085","title":"异动解读 | 再生元制药公司财报超预期，股价盘中大涨6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153428085","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153428085?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:43","pubTimestamp":1754055798,"startTime":"0","endTime":"0","summary":"再生元制药公司今日盘中大涨6.88%，引发市场广泛关注。这一显著涨幅主要源于公司发布的2025年第二季度财报远超市场预期。根据再生元制药公司公布的财报，2025年第二季度收入同比增长4%至36.8亿美元，超过分析师预期的32.84亿美元。除财务业绩外，再生元制药公司还公布了多项积极的业务进展。这些因素共同推动了投资者信心，导致股价大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["REGN"],"gpt_icon":0},{"id":"1178009083","title":"异动解读 | 再生元制药公司发布强劲财报，盘前大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178009083","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178009083?lang=zh_cn&edition=full","pubTime":"2025-08-01 18:36","pubTimestamp":1754044583,"startTime":"0","endTime":"0","summary":"再生元制药公司今日盘前大涨5.06%，主要得益于公司发布的2025年第二季度财报超出市场预期。根据财报显示，再生元制药公司第二季度收入同比增长4%至36.8亿美元，超过分析师预期的32.84亿美元。除了财务业绩外，再生元制药公司还公布了多项积极的业务进展。再生元制药公司还强调了其对内部投资的承诺，自2025年初以来，通过股票回购和股息向股东返还超过23亿美元，同时承诺在美国制造业投资、资本支出和业务发展方面投入超过70亿美元。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["REGN"],"gpt_icon":1},{"id":"2556586861","title":"再生元制药公司7月31日成交额为7.75亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556586861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556586861?lang=zh_cn&edition=full","pubTime":"2025-08-01 13:37","pubTimestamp":1754026644,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，再生元制药公司成交额为7.75亿美元，成交额较昨日增加146.52%，当日成交量为141.38万股。再生元制药公司于2025年7月31日跌1.64%，报545.46美元，该股过去5个交易日跌3.4%，年初至今跌23.21%，过去60日跌9.49%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801133725a46f0053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801133725a46f0053&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2362541273.HKD","LU0289739699.SGD","LU2468319806.SGD","LU1974910355.USD","LU0823434583.USD","LU2106854487.HKD","REGN","BK4585","LU2362540622.SGD","LU1917777945.USD","LU2362541513.USD","LU0882574055.USD","BK4588","LU0114720955.EUR","LU0058720904.USD","LU0320765992.SGD","LU2023250504.SGD","BK4139","LU0823434740.USD","LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU0053666078.USD","LU0109394709.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2554557647","title":"再生元制药公司7月24日成交额为5.88亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554557647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554557647?lang=zh_cn&edition=full","pubTime":"2025-07-25 13:24","pubTimestamp":1753421090,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，再生元制药公司成交额为5.88亿美元，成交额较昨日增加15.21%，当日成交量为103.77万股。再生元制药公司于2025年7月24日跌1.35%，报564.64美元，该股过去5个交易日涨2.66%，年初至今跌20.51%，过去60日跌7.43%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725132459a6c0f739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725132459a6c0f739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2237438978.USD","LU2362541513.USD","LU2362540622.SGD","LU0109394709.USD","LU2468319806.SGD","LU2106854487.HKD","BK4585","LU0823416689.USD","BK4588","LU1917777945.USD","LU1974910355.USD","LU0889565916.HKD","LU0823434583.USD","LU0053666078.USD","LU0823434740.USD","LU0320765992.SGD","LU0882574055.USD","LU2023250504.SGD","BK4139","LU0114720955.EUR","LU0289739699.SGD","LU2362541273.HKD","REGN","LU2089984988.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2553529940","title":"再生元制药公司7月22日成交额为5.46亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553529940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553529940?lang=zh_cn&edition=full","pubTime":"2025-07-23 13:28","pubTimestamp":1753248518,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，再生元制药公司成交额为5.46亿美元，成交额较昨日增加40.56%，当日成交量为97.67万股。再生元制药公司于2025年7月22日涨2.82%，报560.93美元，该股过去5个交易日涨2.37%，年初至今跌21.03%，过去60日跌6.33%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723132842a6bc7e86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723132842a6bc7e86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU1917777945.USD","LU2362540622.SGD","LU1974910355.USD","LU0889565916.HKD","LU2089984988.USD","BK4139","LU0320765992.SGD","LU0823416689.USD","BK4585","LU0823434583.USD","LU0882574055.USD","LU2106854487.HKD","REGN","LU0823434740.USD","LU0289739699.SGD","LU0058720904.USD","LU0053666078.USD","LU2237438978.USD","LU2023250504.SGD","LU2362541513.USD","LU2468319806.SGD","LU2362541273.HKD","LU0114720955.EUR","BK4588"],"gpt_icon":0},{"id":"2552543234","title":"再生元制药公司7月17日成交额为5.45亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552543234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552543234?lang=zh_cn&edition=full","pubTime":"2025-07-18 13:16","pubTimestamp":1752815789,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，再生元制药公司成交额为5.45亿美元，成交额较昨日减少9.33%，当日成交量为98.93万股。再生元制药公司于2025年7月17日涨0.38%，报550.0美元，该股过去5个交易日跌1.74%，年初至今跌22.57%，过去60日跌1.9%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718131639a6b14714&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718131639a6b14714&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","LU2362540622.SGD","LU0882574055.USD","LU0823416689.USD","LU0889565916.HKD","LU0823434583.USD","LU2023250504.SGD","LU2362541273.HKD","LU2362541513.USD","BK4139","LU2237438978.USD","LU0109394709.USD","LU0289739699.SGD","LU1974910355.USD","REGN","LU2089984988.USD","LU0114720955.EUR","LU0823434740.USD","LU2106854487.HKD","BK4588","LU0053666078.USD","BK4585","LU0320765992.SGD","LU1917777945.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2551126371","title":"再生元制药公司7月15日成交额为5.52亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126371?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:26","pubTimestamp":1752643619,"startTime":"0","endTime":"0","summary":"美东时间2025年7月15日，再生元制药公司成交额为5.52亿美元，成交额较昨日增加35.05%，当日成交量为99.86万股。再生元制药公司于2025年7月15日跌3.97%，报547.96美元，该股过去5个交易日涨0.04%，年初至今跌22.86%，过去60日跌0.09%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-15|5.52亿|35.05%|99.86万|#|2025-07-14|4.09亿|-14.27%|71.71万|#|2025-07-11|4.77亿|2.92%|84.46万|#|2025-07-10|4.64亿|-0.37%|82.77万|#|2025-07-09|4.65亿|-0.25%|84.39万|Regeneron Pharmaceuticals 发现、开发和商业化用于治疗眼部疾病、心血管疾病、癌症和炎症的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716132703a44de261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716132703a44de261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053666078.USD","LU1974910355.USD","BK4588","LU0058720904.USD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","LU0823416689.USD","LU2362541273.HKD","BK4139","LU0289739699.SGD","LU0882574055.USD","LU0823434583.USD","LU0823434740.USD","LU2237438978.USD","LU0114720955.EUR","REGN","LU2106854487.HKD","LU2362541513.USD","LU2023250504.SGD","LU1917777945.USD","LU0889565916.HKD","LU2362540622.SGD","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2551196978","title":"再生元制药公司7月14日成交额为4.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551196978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551196978?lang=zh_cn&edition=full","pubTime":"2025-07-15 13:25","pubTimestamp":1752557141,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，再生元制药公司成交额为4.09亿美元，成交额较昨日减少14.27%，当日成交量为71.71万股。再生元制药公司于2025年7月14日涨0.5%，报570.59美元，该股过去5个交易日涨6.04%，年初至今跌19.67%，过去60日涨2.43%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715132549a6aa4bcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715132549a6aa4bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089984988.USD","BK4585","LU2023250504.SGD","LU0109394709.USD","LU2237438978.USD","BK4588","LU0320765992.SGD","LU2468319806.SGD","LU2362540622.SGD","BK4139","LU0889565916.HKD","LU2106854487.HKD","LU0823416689.USD","LU0882574055.USD","LU0114720955.EUR","LU2362541513.USD","LU2362541273.HKD","LU0823434740.USD","LU0053666078.USD","LU0058720904.USD","REGN","LU1917777945.USD","LU1974910355.USD","LU0289739699.SGD","LU0823434583.USD"],"gpt_icon":0},{"id":"2550312999","title":"再生元制药公司7月11日成交额为4.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550312999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550312999?lang=zh_cn&edition=full","pubTime":"2025-07-12 13:14","pubTimestamp":1752297289,"startTime":"0","endTime":"0","summary":"美东时间2025年7月11日，再生元制药公司成交额为4.77亿美元，成交额较昨日增加2.92%，当日成交量为84.46万股。再生元制药公司于2025年7月11日涨1.43%，报567.74美元，该股过去5个交易日涨3.72%，年初至今跌20.07%，过去60日跌0.43%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712131456a4460f7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712131456a4460f7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","LU0109394709.USD","LU2237438978.USD","LU0058720904.USD","LU1974910355.USD","LU0289739699.SGD","REGN","LU0823434583.USD","LU0823416689.USD","LU2089984988.USD","LU0053666078.USD","LU0823434740.USD","LU2362540622.SGD","LU2106854487.HKD","BK4588","LU2362541273.HKD","LU0320765992.SGD","LU2023250504.SGD","LU2362541513.USD","LU0882574055.USD","LU2468319806.SGD","BK4139","LU0114720955.EUR","LU1917777945.USD"],"gpt_icon":0},{"id":"2550692989","title":"再生元制药公司7月9日成交额为4.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550692989","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550692989?lang=zh_cn&edition=full","pubTime":"2025-07-10 13:22","pubTimestamp":1752124949,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，再生元制药公司成交额为4.65亿美元，成交额较昨日减少0.25%，当日成交量为84.39万股。再生元制药公司于2025年7月9日涨0.88%，报552.58美元，该股过去5个交易日涨3.3%，年初至今跌22.21%，过去60日涨1.28%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710132235a6a0d2b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710132235a6a0d2b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823434583.USD","LU2362541513.USD","LU0320765992.SGD","LU0114720955.EUR","LU0823416689.USD","LU2023250504.SGD","LU2362541273.HKD","LU0058720904.USD","LU0823434740.USD","LU1917777945.USD","LU2362540622.SGD","LU2089984988.USD","BK4139","LU0889565916.HKD","BK4585","BK4588","LU0882574055.USD","LU2468319806.SGD","LU0109394709.USD","LU0053666078.USD","LU2237438978.USD","LU1974910355.USD","REGN","LU0289739699.SGD","LU2106854487.HKD"],"gpt_icon":0},{"id":"2550507822","title":"再生元制药公司7月8日成交额为4.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550507822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550507822?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:22","pubTimestamp":1752038547,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，再生元制药公司成交额为4.66亿美元，成交额较昨日减少9.67%，当日成交量为84.74万股。再生元制药公司于2025年7月8日涨1.79%，报547.75美元，该股过去5个交易日涨4.33%，年初至今跌22.89%，过去60日跌4.88%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709132236a43f8676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709132236a43f8676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0114720955.EUR","LU0053666078.USD","LU2023250504.SGD","LU1917777945.USD","LU2106854487.HKD","LU0109394709.USD","LU0823416689.USD","LU0889565916.HKD","BK4585","LU0058720904.USD","BK4139","LU0320765992.SGD","LU0882574055.USD","LU2362541513.USD","LU0823434740.USD","REGN","LU0823434583.USD","LU2362541273.HKD","BK4588","LU2237438978.USD","LU2089984988.USD","LU1974910355.USD","LU2468319806.SGD","LU2362540622.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2549570594","title":"再生元制药公司7月7日成交额为5.16亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549570594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549570594?lang=zh_cn&edition=full","pubTime":"2025-07-08 13:14","pubTimestamp":1751951687,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，再生元制药公司成交额为5.16亿美元，成交额较昨日增加106.35%，当日成交量为96.03万股。再生元制药公司于2025年7月7日跌1.69%，报538.11美元，该股过去5个交易日涨3.28%，年初至今跌24.25%，过去60日跌3.21%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708131458a69c5e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708131458a69c5e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REGN","LU0289739699.SGD","LU1974910355.USD","BK4139","LU0823434583.USD","BK4585","LU0053666078.USD","LU0882574055.USD","LU0320765992.SGD","LU2106854487.HKD","BK4588","LU0109394709.USD","LU2023250504.SGD","LU2089984988.USD","LU2468319806.SGD","LU0889565916.HKD","LU0058720904.USD","LU0823434740.USD","LU0823416689.USD","LU2237438978.USD","LU2362541513.USD","LU2362540622.SGD","LU2362541273.HKD","LU0114720955.EUR","LU1917777945.USD"],"gpt_icon":0},{"id":"2548029485","title":"再生元制药公司6月30日成交额为5.30亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548029485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548029485?lang=zh_cn&edition=full","pubTime":"2025-07-01 12:55","pubTimestamp":1751345753,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，再生元制药公司成交额为5.30亿美元，成交额较昨日减少36.71%，当日成交量为101.33万股。再生元制药公司于2025年6月30日涨0.77%，报525.0美元，该股过去5个交易日涨2.56%，年初至今跌26.09%，过去60日跌15.95%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701125603a4c81c69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701125603a4c81c69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053666078.USD","LU2023250504.SGD","LU0114720955.EUR","LU0109394709.USD","LU0823416689.USD","LU1974910355.USD","LU2468319806.SGD","LU2089984988.USD","LU0823434583.USD","LU0289739699.SGD","LU2362541513.USD","LU2362541273.HKD","LU1917777945.USD","BK4585","BK4588","LU2106854487.HKD","LU0058720904.USD","REGN","LU0889565916.HKD","LU0320765992.SGD","LU0882574055.USD","BK4139","LU2362540622.SGD","LU0823434740.USD","LU2237438978.USD"],"gpt_icon":0},{"id":"2546798954","title":"再生元制药公司6月26日成交额为5.02亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546798954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546798954?lang=zh_cn&edition=full","pubTime":"2025-06-27 13:01","pubTimestamp":1751000492,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日，再生元制药公司成交额为5.02亿美元，成交额较昨日增加50.78%，当日成交量为96.56万股。再生元制药公司于2025年6月26日涨0.14%，报521.0美元，该股过去5个交易日涨1.44%，年初至今跌26.65%，过去60日跌17.73%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627130136a4c056e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627130136a4c056e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089984988.USD","BK4585","LU2023250504.SGD","LU0109394709.USD","LU2237438978.USD","BK4588","LU0320765992.SGD","LU2468319806.SGD","LU2362540622.SGD","BK4139","LU0889565916.HKD","LU2106854487.HKD","LU0823416689.USD","LU0882574055.USD","LU0114720955.EUR","LU2362541513.USD","LU2362541273.HKD","LU0823434740.USD","LU0053666078.USD","LU0058720904.USD","REGN","LU1917777945.USD","LU1974910355.USD","LU0289739699.SGD","LU0823434583.USD"],"gpt_icon":0},{"id":"2546262483","title":"再生元制药公司6月24日成交额为5.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546262483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546262483?lang=zh_cn&edition=full","pubTime":"2025-06-25 13:18","pubTimestamp":1750828710,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，再生元制药公司成交额为5.07亿美元，成交额较昨日减少7.94%，当日成交量为97.06万股。再生元制药公司于2025年6月24日涨2.02%，报522.27美元，该股过去5个交易日跌0.08%，年初至今跌26.48%，过去60日跌17.74%。该公司有多种已上市产品，包括获批用于湿性年龄相关性黄斑变性和其他眼病的低剂量Eylea 和 Eylea HD、免疫学领域的达必妥；用于降低低密度脂蛋白胆固醇的波立达；肿瘤学领域的Libtayo；以及类风湿性关节炎领域的Kevzara。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625131831a4bcaaf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625131831a4bcaaf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU1917777945.USD","LU2362540622.SGD","LU1974910355.USD","LU0889565916.HKD","LU2089984988.USD","BK4139","LU0320765992.SGD","LU0823416689.USD","BK4585","LU0823434583.USD","LU0882574055.USD","LU2106854487.HKD","REGN","LU0823434740.USD","LU0289739699.SGD","LU0058720904.USD","LU0053666078.USD","LU2237438978.USD","LU2023250504.SGD","LU2362541513.USD","LU2468319806.SGD","LU2362541273.HKD","LU0114720955.EUR","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regeneron.com","stockEarnings":[{"period":"1week","weight":0.0263},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0607},{"period":"6month","weight":-0.2115},{"period":"1year","weight":-0.4757},{"period":"ytd","weight":-0.2141}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.0192},{"period":"3month","weight":0.1203},{"period":"6month","weight":0.0524},{"period":"1year","weight":0.219},{"period":"ytd","weight":0.0788}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"再生元制药公司于1988年在纽约州成立。再生元制药公司是一家完全集成的生物技术公司，它发现、发明、开发、制造和商业化治疗严重疾病的药物。其正在开发的商业化药物和候选产品旨在帮助患有眼疾、过敏性和炎症性疾病、癌症、心血管和代谢性疾病、疼痛、传染病和罕见疾病的患者。它的核心业务战略是在基础科学研究和发现启用技术方面保持坚实的基础，并建立在临床开发、制造和商业能力的基础上。其目标是继续成为一家综合性、多产品的生物技术公司，为患者和医疗专业人员提供预防和治疗人类疾病的重要选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.529412,"avgChangeRate":0.03899},{"month":2,"riseRate":0.411765,"avgChangeRate":0.087815},{"month":3,"riseRate":0.470588,"avgChangeRate":-0.044318},{"month":4,"riseRate":0.470588,"avgChangeRate":0.017191},{"month":5,"riseRate":0.628571,"avgChangeRate":0.057479},{"month":6,"riseRate":0.428571,"avgChangeRate":0.006745},{"month":7,"riseRate":0.657143,"avgChangeRate":0.052646},{"month":8,"riseRate":0.542857,"avgChangeRate":0.021782},{"month":9,"riseRate":0.470588,"avgChangeRate":0.0249},{"month":10,"riseRate":0.382353,"avgChangeRate":-0.006135},{"month":11,"riseRate":0.529412,"avgChangeRate":0.041578},{"month":12,"riseRate":0.5,"avgChangeRate":0.045405}],"exchange":"NASDAQ","name":"再生元制药公司","nameEN":"Regeneron Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再生元制药公司(REGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再生元制药公司(REGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再生元制药公司,REGN,再生元制药公司股票,再生元制药公司股票老虎,再生元制药公司股票老虎国际,再生元制药公司行情,再生元制药公司股票行情,再生元制药公司股价,再生元制药公司股市,再生元制药公司股票价格,再生元制药公司股票交易,再生元制药公司股票购买,再生元制药公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再生元制药公司(REGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再生元制药公司(REGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}